Abbott: Sturgis facility could restart within two weeks

Parents throughout the US are scrambling to find baby formula because of supply disruptions and a massive safety recall from Abbott Nutrition in regard to its Sturgis manufacturing facility.

Months of spot shortages at pharmacies and supermarkets have been exacerbated by the recall at Abbott, which was forced to shutter its Sturgis facility – the largest US formula manufacturing plant – in February due to contamination concerns.

“We understand the situation is urgent – getting Sturgis up and running will help alleviate this shortage,” Abbott officials said Wednesday. “Subject to FDA approval, we could restart the site within two weeks. We would begin production of EleCare, Alimentum and metabolic formulas first and then begin production of Similac and other formulas. From the time we restart the site, it will take six to eight weeks before the product is available on shelves. ”

Leave a Comment